These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 33097283)
1. Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor. Gillis A; Kliewer A; Kelly E; Henderson G; Christie MJ; Schulz S; Canals M Trends Pharmacol Sci; 2020 Dec; 41(12):947-959. PubMed ID: 33097283 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor. Mafi A; Kim SK; Goddard WA Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232 [TBL] [Abstract][Full Text] [Related]
3. G protein signaling-biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists. Stahl EL; Schmid CL; Acevedo-Canabal A; Read C; Grim TW; Kennedy NM; Bannister TD; Bohn LM Proc Natl Acad Sci U S A; 2021 Nov; 118(48):. PubMed ID: 34819362 [TBL] [Abstract][Full Text] [Related]
4. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform. Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045 [TBL] [Abstract][Full Text] [Related]
5. Biased versus Partial Agonism in the Search for Safer Opioid Analgesics. Azevedo Neto J; Costanzini A; De Giorgio R; Lambert DG; Ruzza C; Calò G Molecules; 2020 Aug; 25(17):. PubMed ID: 32854452 [TBL] [Abstract][Full Text] [Related]
6. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance. Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067 [TBL] [Abstract][Full Text] [Related]
7. The μ-opioid receptor-mediated G Xia J; Li X; Zhu H; Zhou X; Chen J; Li Q; Li S; Chu H; Dong M Eur J Pharmacol; 2024 Mar; 966():176333. PubMed ID: 38278466 [TBL] [Abstract][Full Text] [Related]
8. Characterization of structurally novel G protein biased CB Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808 [TBL] [Abstract][Full Text] [Related]
9. Discovery and Structural Explorations of G-Protein Biased μ-Opioid Receptor Agonists. Li X; Guo Y; Li J; Yu Z; Cheng J; Ren F; Jia H; Zhang Y; Cui S; Zhang T; Shi W ChemMedChem; 2022 Dec; 17(24):e202200416. PubMed ID: 36210341 [TBL] [Abstract][Full Text] [Related]
10. Morphine-induced respiratory depression is independent of β-arrestin2 signalling. Kliewer A; Gillis A; Hill R; Schmiedel F; Bailey C; Kelly E; Henderson G; Christie MJ; Schulz S Br J Pharmacol; 2020 Jul; 177(13):2923-2931. PubMed ID: 32052419 [TBL] [Abstract][Full Text] [Related]
11. Signaling diversity of mu- and delta- opioid receptor ligands: Re-evaluating the benefits of β-arrestin/G protein signaling bias. Pineyro G; Nagi K Cell Signal; 2021 Apr; 80():109906. PubMed ID: 33383156 [TBL] [Abstract][Full Text] [Related]
12. A Biased View of Conibear AE; Kelly E Mol Pharmacol; 2019 Nov; 96(5):542-549. PubMed ID: 31175184 [TBL] [Abstract][Full Text] [Related]
13. An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects. French AR; van Rijn RM Pharmacol Res; 2022 Mar; 177():106091. PubMed ID: 35101565 [TBL] [Abstract][Full Text] [Related]
14. Carfentanil is a β-arrestin-biased agonist at the μ opioid receptor. Ramos-Gonzalez N; Groom S; Sutcliffe KJ; Bancroft S; Bailey CP; Sessions RB; Henderson G; Kelly E Br J Pharmacol; 2023 Sep; 180(18):2341-2360. PubMed ID: 37005796 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591 [TBL] [Abstract][Full Text] [Related]
16. Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window. Gillis A; Sreenivasan V; Christie MJ Mol Pharmacol; 2020 Oct; 98(4):410-424. PubMed ID: 32665252 [TBL] [Abstract][Full Text] [Related]
17. Biased Agonism of Endogenous Opioid Peptides at the μ-Opioid Receptor. Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M Mol Pharmacol; 2015 Aug; 88(2):335-46. PubMed ID: 26013541 [TBL] [Abstract][Full Text] [Related]
18. Quantitative Systems Pharmacology and Biased Agonism at Opioid Receptors: A Potential Avenue for Improved Analgesics. Bedini A; Cuna E; Baiula M; Spampinato S Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563502 [TBL] [Abstract][Full Text] [Related]
19. A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein-coupled receptor kinase. Groom S; Blum NK; Conibear AE; Disney A; Hill R; Husbands SM; Li Y; Toll L; Kliewer A; Schulz S; Henderson G; Kelly E; Bailey CP Br J Pharmacol; 2023 Apr; 180(7):943-957. PubMed ID: 33245558 [TBL] [Abstract][Full Text] [Related]
20. A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptor. Dekan Z; Sianati S; Yousuf A; Sutcliffe KJ; Gillis A; Mallet C; Singh P; Jin AH; Wang AM; Mohammadi SA; Stewart M; Ratnayake R; Fontaine F; Lacey E; Piggott AM; Du YP; Canals M; Sessions RB; Kelly E; Capon RJ; Alewood PF; Christie MJ Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22353-22358. PubMed ID: 31611414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]